期刊文献+

真菌对唑类抗真菌药物相关耐药基因的研究进展 被引量:2

The Research Advance of Fungi Resistance Genes toward Azoles-Antifungal Drug
下载PDF
导出
摘要 近年来随着真菌感染频率的增高,唑类抗真菌药物随之被越来越多运用于临床治疗中,但耐药率逐年上升,成为困扰临床治疗真菌感染的难题之一。真菌对唑类药物耐药性的产生是多种复杂因素作用的结果,但主要是由于某些靶酶及耐药基因表达的增加造成的。文章着重介绍真菌唑类药物耐药性产生的机制以及相关耐药基因的研究进展,为临床合理使用唑类药物和研发新型抗真菌药物提供用药策略及理论指导。 In recent years,with the increasing incidence of fungal infections,azole-antifungal drugs are increasingly used in the clinical treatment,and fungi′s resistance rates increase rapidly year by year,and have become difficulties in clinical treatment of fungal infections.Fungi′s resistance to azole drug is the result of a variety of complex factors,but main reason is the increase expression of resistance genes and target enzyme.This article focuses on the resistance mechanisms of fungal to azole-drug and associated resistance genes,with the view to provide medication strategies and theoretical guidance for rational use of antifungal agent in clinic and for new antifungal drugs research.
作者 姚婉玉 梁伶
出处 《医学综述》 2010年第5期665-669,共5页 Medical Recapitulate
关键词 真菌 唑类药物 耐药基因 Fungi Azole-drug Resistance gene
  • 相关文献

参考文献24

二级参考文献92

  • 1石婧,张宏.白念珠菌菌丝相和酵母相ERG11基因部分序列差异性的探讨[J].中华皮肤科杂志,2004,37(8):472-474. 被引量:11
  • 2韩旭东,张永信.主动外排系统与白念珠菌耐药关系研究[J].中华传染病杂志,2004,22(4):229-233. 被引量:3
  • 3佘菲菲,沈建箴,吕联煌,陈月秀,郑秀芬.快速高效提取白色念珠菌DNA[J].福建医学院学报,1996,30(3):220-222. 被引量:6
  • 4乔建军,刘伟,曹存巍,万哲,李若瑜.额外拷贝ERG6基因对烟曲霉的影响[J].微生物学通报,2007,34(1):191-194. 被引量:3
  • 5廖万清,顾菊林.深部真菌感染治疗的现状与对策[J].中国感染与化疗杂志,2007,7(2):101-103. 被引量:37
  • 6National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. NCCLS document M38-A [ M ]. American: National Committee for Clinical Laboratory Standards, 2002.
  • 7Hohmann S. Osmotic stress signaling and osmoadaptation in yeasts [J]. Mierobiol Mol Biol Rev, 2002, 66(2) : 300 -372.
  • 8Singh KK. The Saccharomyces cerevisiae Slnlp-Ssklp two-component system mediates response to oxidative stress and in an oxidantspecific fashion [ J]. Free Radic Biol Med, 2000, 29 (10): 1043 - 1050.
  • 9Roman E, Nombela C, Pla J. The Shol adaptor protein links oxidative stress to morphogenesis and cell wall biosynthesis in the fungal pathogen Candida albicans [ J ]. Mol Cell Biol, 2005, 25 (23) : 10611 - 10627.
  • 10Ma Yah, Qiao Janjun, Liu Wei, et al. The shol sensor regulates growth, morphology, and oxidant adaptation in Aspergillus fumigatus but is not essential for development of invasive pulmonary aspergillosis [J]. Infect Immun, 2008, 76(4) : 1695 -1701.

共引文献43

同被引文献27

  • 1杨丽娜,祁文瑾,肖虹.外阴阴道白假丝酵母菌病耐药机制研究进展[J].昆明医学院学报,2012,33(3):143-146. 被引量:2
  • 2孙长贵,曾贤铭,杨燕.酵母样真菌对抗真菌药物耐药性研究进展[J].临床检验杂志,2006,24(6):474-475. 被引量:14
  • 3徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 4PEREA S, LOPEZ RIBOT J L, KIRKPATRICK W R, et al. Prevalence of molecular mechanisms of resistance to azole antifun- gal agents in Candida albicans strains displaying high - level flu- conazole resistance isolated from human immuno - deficiency virus-infected patients [ J]. Antimicrob Agents Chemother, 2001, 45(10): 2676-2684.
  • 5HOOT S J, SMITH A R, BROWN R P, et al. An A643V amino acid substitution in Upc2p contributes to azole resistance in well - characterized clinical isolates of Candida albicans[ J ]. Antimicrob Agents Chemother, 2011,55 ( 2 ) : 940 - 942.
  • 6XU Y H, CHEN L M, LI C Y. Susceptibility of clinical isolates of Candida species to flueonazole and detection of Candida albieans ERGll mutations[J]. J Antimicrob Chemother, 2008, 61 (4): 798 - 804.
  • 7PARK S, PERLIN D S. Establishing surrogate markers for flucon- azole resistance in Candida albicans [ J ]. Microb Drug Resist, 2005, 11(3) : 232 -238.
  • 8KELLY S L, LAMB D C, LOEFFLER J, et al. The G464S amino acid substitution in Candida albicans sterol 14alpha - demethylase causes fiuconazole resistance in the clinic through reduced affinity [ J]. Biochem Biophys Res Commun, 1999, 262( 1 ) : 174 - 183.
  • 9GAUR M, CHOUDHURY D, PRASAD R. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans[J3. J Mol Microbiol Biotechnel, 2005, 9( 1 ) : 3 -15.
  • 10OLIVER B G, SILVER P M, MARIE C, et al. Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi [J]. Microbiology, 2008, 154(4) : 960 -970.

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部